Form CORRESP - Correspondence:
SEC Accession No. 0001140361-24-002650
Filing Date
2024-01-18
Accepted
2024-01-18 11:15:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5940
  Complete submission text file 0001140361-24-002650.txt   7208
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)